Free Trial

BeiGene (BGNE) SEC Filings & 10K Form

BeiGene logo
$189.23 -4.06 (-2.10%)
(As of 11/15/2024 ET)

Recent BeiGene SEC Filings

DateFilerForm TypeView
11/14/2024
5:05 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
5:29 PM
BeiGene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SC 13D/A
10/31/2024
4:40 PM
BeiGene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SCHEDULE 13D/A
10/28/2024
5:05 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:48 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:23 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:24 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
6:13 PM
BeiGene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:16 PM
BeiGene (Issuer)
Sharp Shalini (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
6:21 PM
BeiGene (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:29 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:27 PM
BeiGene (Subject)
Lee Chan Henry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
5:02 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
5:12 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
4:25 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:40 PM
BeiGene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
4:40 PM
Ball Titus B. (Reporting)
BeiGene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:41 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:19 PM
BeiGene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
6:29 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:30 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
4:27 PM
BeiGene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:17 PM
BeiGene (Issuer)
Rosenberg Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:32 AM
BeiGene (Filer)
Form S-4
Registration statement under Securities Act of 1933  
08/07/2024
5:04 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
5:07 AM
BeiGene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
4:06 PM
BeiGene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
4:23 PM
BeiGene (Issuer)
Rosenberg Aaron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
5:40 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
4:05 PM
BeiGene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:18 PM
BeiGene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:22 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:24 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:25 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:26 PM
BeiGene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:30 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:19 PM
BeiGene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:23 PM
BeiGene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:25 PM
BeiGene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
4:27 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:24 PM
BeiGene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[Urgent] Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.
06/20/2024
4:25 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:25 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:26 PM
BeiGene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:50 PM
BeiGene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:50 PM
BeiGene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:53 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:57 PM
BeiGene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:01 PM
BeiGene (Issuer)
BRANDICOURT OLIVIER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:02 PM
BeiGene (Issuer)
Dugan Margaret (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:03 PM
BeiGene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:03 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:04 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Ball Titus B. (Reporting)
BeiGene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:31 PM
BeiGene (Issuer)
Yi Qingqing (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:23 PM
BeiGene (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/05/2024
3:35 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:25 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
5:06 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
5:09 AM
BeiGene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:21 PM
BeiGene (Filer)
Form ARS
04/26/2024
3:16 PM
BeiGene (Filer)
Form DEF 14A
04/26/2024
6:15 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:13 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:27 PM
BeiGene (Filer)
Form PRE 14A
04/11/2024
5:01 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:21 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
4:26 PM
Ball Titus B. (Reporting)
BeiGene (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:10 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
4:23 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
4:04 PM
BeiGene (Issuer)
Glazer Donald W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:01 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
5:16 AM
BeiGene (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
5:02 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:12 PM
BeiGene (Subject)
OYLER JOHN (Filed by)
Form SC 13G/A
01/23/2024
5:03 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
5:01 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:44 PM
BeiGene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BGNE) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners